Establishing certain notification and reporting requirements concerning pilot programs that research transcranial magnetic stimulation or electromagnetic brain pulse treatment. (BDR S-865)
Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date.
Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date.
Controlled dangerous substances; authorizing certain research and clinical trials related to psilocybin and psilocin; requiring registration; providing certain immunities.